--Indian pharmaceutical group Dr. Reddy's Laboratories is in ongoing talks to buy the anti-smoking aid Nicotinell from Haleon, Sky News reports, citing unnamed sources.

--Financial details regarding how much Dr Reddy's might pay to Haleon--which was spun out of GSK and Pfizer's consumer-healthcare business--remain unclear, but it is unlikely to be as much as the $800 million suggested in a previous report, Sky News reports.

--The companies weren't immediately available for comment.

Full story: https://bit.ly/3HFrAOx

Write to Michael Susin at michael.susin@wsj.com

(END) Dow Jones Newswires

January 16, 2024 08:43 ET (13:43 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.
Dr Reddys Laboratories (NYSE:RDY)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024 Click aqui para mais gráficos Dr Reddys Laboratories.
Dr Reddys Laboratories (NYSE:RDY)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024 Click aqui para mais gráficos Dr Reddys Laboratories.